Literature DB >> 29871559

The Possible Role of Eukaryotic Translation Initiation Factor 3 Subunit e (eIF3e) in the Epithelial-Mesenchymal Transition in Adenomyosis.

Xianjun Cai1, Minhong Shen2, Xishi Liu2, Jichan Nie2.   

Abstract

Epithelial-mesenchymal transition (EMT) has been reported to be involved in adenomyosis by promoting cell invasion and fibrogenesis. But few studies have identified critical factors that regulate EMT process during adenomyosis. The eukaryotic translation initiation factor 3 subunit e (eIF3e) protein is a component of the multisubunit eIF3 complex essential for cap-dependent translation initiation. The aim of this study was to investigate whether eIF3e is involved in EMT in adenomyosis. Ectopic endometrial tissue samples were collected from 40 premenopausal women with ultrasonographically diagnosed and histologically confirmed adenomyosis. As controls, endometrial samples were obtained from 40 cycling premenopausal women patients who underwent surgery for benign gynecologic disorders or cervical intraepithelial neoplasia but without endometriosis, adenomyosis, nor uterine fibroids. All tissue samples were subjected to immunohistochemistry analysis of eIF3e, transforming growth factor-β1 (TGF-β1), E-cadherin, vimentin, Snail, and proliferating cell nuclear antigen (PCNA). The epithelial component of ectopic endometrium showed significantly reduced immunoreactivity against eIF3e and E-cadherin but elevated immunoreactivity against TGF-β1, Snail, vimentin, and PCNA as compared with that of control endometrium (all P values <.05), and the difference was not affected by age, parity, or menstrual phase. The eIF3e staining levels correlated negatively with those of TGF-β1, vimentin, Snail, and PCNA (both P values <.05). These data suggest that decreased eIF3e expression may pave way for EMT in the development of adenomyosis through activating the TGF-β1 signaling pathway. Our study provided novel insights into the development and treatments of adenomyosis.

Entities:  

Keywords:  TGF-β1; adenomyosis; eIF3e; epithelial–mesenchymal transition

Mesh:

Substances:

Year:  2018        PMID: 29871559     DOI: 10.1177/1933719118773490

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  5 in total

1.  Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review.

Authors:  Marissa J Harmsen; Caroline F C Wong; Velja Mijatovic; Arjan W Griffioen; Freek Groenman; Wouter J K Hehenkamp; Judith A F Huirne
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

2.  A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis.

Authors:  Xuan Che; Jianzhang Wang; Jiayi He; Qin Yu; Wenting Sun; Shuyi Chen; Gen Zou; Tiantian Li; Xinyue Guo; Xinmei Zhang
Journal:  J Cell Mol Med       Date:  2019-12-08       Impact factor: 5.310

3.  Single-cell transcriptomic analysis of eutopic endometrium and ectopic lesions of adenomyosis.

Authors:  Zhiyong Liu; Zhonghua Sun; Hongyun Liu; Weipin Niu; Xin Wang; Na Liang; Xin Wang; Yanfei Wang; Yaxin Shi; Li Xu; Wei Shi
Journal:  Cell Biosci       Date:  2021-03-08       Impact factor: 7.133

4.  A Joint Model of Random Forest and Artificial Neural Network for the Diagnosis of Endometriosis.

Authors:  Jiajie She; Danna Su; Ruiying Diao; Liping Wang
Journal:  Front Genet       Date:  2022-03-08       Impact factor: 4.599

Review 5.  The Role of mTOR and eIF Signaling in Benign Endometrial Diseases.

Authors:  Tatiana S Driva; Christoph Schatz; Monika Sobočan; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.